Mara is an associate in Cooley’s corporate practice group. She advises clients through every stage of a company’s life cycle, including venture financings, initial public offerings and mergers & acquisitions. Her clients vary from life sciences and tech companies to nonprofits.
Hummingbird Bioscience Announces Exclusive Worldwide License Agreement With Callio Therapeutics
March 3, 2025
Cooley advised Hummingbird Bioscience, a Singapore-based biotherapeutics company working at the interface of artificial intelligence and human innovation to discover and develop transformative medicines for hard-to-treat diseases, on its exclusive worldwide license agreement with Callio Therapeutics, a newly launched biotech company focused on realizing the promise of multipayload antibody-drug conjugates (ADCs) to improve cancer therapy.
Battery Ventures-Backed PageUp To Be Acquired by EQT Partners
October 31, 2024
Cooley advised Battery Ventures, a global, technology-focused investment firm, and PageUp Group, a human resources and talent software company that had been majority owned by Battery, on the sale of PageUp to EQT Group.
Cooley advised Cobre, a Colombia-based treasury platform that has been powering top Latin American chief financial officer (CFO) offices since 2020, on its $35 million Series B funding.
